Randomized, Controlled Trial of a Digital Behavioral Therapeutic Application to Improve Glycemic Control in Adults With Type 2 Diabetes.

Judith HsiaNicole L GuthriePaul LupinacciAnanda GubbiDouglas DenhamMark A BermanMarc P Bonaca

Published in: Diabetes care (2022)

Patients randomly assigned to the BT-001 arm relative to the control arm had significantly lower HbA1c at 90 days. The digital therapeutic may provide a scalable treatment option for patients with type 2 diabetes.

Keyphrases

glycemic control
randomized controlled trial
end stage renal disease
type diabetes
ejection fraction
newly diagnosed
chronic kidney disease
study protocol
prognostic factors
peritoneal dialysis
clinical trial
metabolic syndrome
adipose tissue
patient reported outcomes
insulin resistance
combination therapy